125 related articles for article (PubMed ID: 6284653)
1. The cooperation of cefotaxime and desacetyl-cefotaxime with respect to antibacterial activity and beta-lactamase stability.
Limbert M; Seibert G; Schrinner E
Infection; 1982; 10(2):97-100. PubMed ID: 6284653
[TBL] [Abstract][Full Text] [Related]
2. Cefotaxime and desacetylcefotaxime: an example of advantageous antimicrobial metabolism.
Chin NX; Neu HC
Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):21S-31S. PubMed ID: 6086215
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial activity of combined cefotaxime and desacetyl-cefotaxime against aerobic and anaerobic gram-negative bacilli.
Marone P; Navarra A; Monzillo V; Traverso A
Drugs Exp Clin Res; 1990; 16(12):629-33. PubMed ID: 2130005
[TBL] [Abstract][Full Text] [Related]
4. The action of beta-lactamases on desacetyl-cefotaxime and cefotaxime.
Labia R; Morand A; Kazmierczak A
J Antimicrob Chemother; 1984 Sep; 14 Suppl B():45-51. PubMed ID: 6094462
[TBL] [Abstract][Full Text] [Related]
5. The in vitro antimicrobial activity of desacetylcefotaxime compared to other related beta-lactams.
Schrinner E; Limbert M; Seeger K; Seibert G; Novick WJ
Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):13S-20S. PubMed ID: 6086214
[TBL] [Abstract][Full Text] [Related]
6. Comparative in vitro studies on cefotaxime and desacetylcefotaxime.
Selwyn S; Bakhtiar M
Drugs Exp Clin Res; 1986; 12(12):953-65. PubMed ID: 3494587
[TBL] [Abstract][Full Text] [Related]
7. Ceftriaxone: a summary of in vitro antibacterial qualities including recommendations for susceptibility tests with 30-micrograms disks.
Jones RN; Barry AL; Thornsberry C
Diagn Microbiol Infect Dis; 1983 Dec; 1(4):295-311. PubMed ID: 6321093
[TBL] [Abstract][Full Text] [Related]
8. [Sensitivity to cefotiam of 494 hospital bacterial strains. Determination of minimal inhibitory concentration and comparison with other beta-lactams].
Reynaud A; Desnoes M; Derriennic M; Courtieu AL
Pathol Biol (Paris); 1985 May; 33(5):313-9. PubMed ID: 3929216
[TBL] [Abstract][Full Text] [Related]
9. Cefodizime, an aminothiazolylcephalosporin. I. In vitro activity.
Limbert M; Klesel N; Seeger K; Seibert G; Winkler I; Schrinner E
J Antibiot (Tokyo); 1984 Aug; 37(8):892-900. PubMed ID: 6090373
[TBL] [Abstract][Full Text] [Related]
10. The Antibacterial activity in vitro and beta-lactamase stability of the new cephalosporin HR 810 in comparison with five other cephalosporins and two aminoglycosides.
Seibert G; Limbert M; Winkler I; Dick T
Infection; 1983; 11(5):275-9. PubMed ID: 6315595
[TBL] [Abstract][Full Text] [Related]
11. Ceftazidime: in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics.
Phillips I; Warren C; Shannon K; King A; Hanslo D
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():23-31. PubMed ID: 19802967
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity and beta-lactamase stability of cefodizime, an aminothiazolyl iminomethoxy cephalosporin.
Scully BE; Jules K; Neu HC
Antimicrob Agents Chemother; 1983 Jun; 23(6):907-13. PubMed ID: 6311090
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of cefotaxime against clinically significant pathogens.
Nakashio S; Nakamura M
Drugs; 1988; 35 Suppl 2():14-21. PubMed ID: 3260852
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of temocillin, moxalactam and cefotaxime against gram negative bacteria sensitive or resistant to ureidopenicillins and/or cefacedone.
Bartmann K; Tarbuc R
Zentralbl Bakteriol Mikrobiol Hyg A; 1983 Dec; 256(2):202-10. PubMed ID: 6324518
[TBL] [Abstract][Full Text] [Related]
15. Ceftriaxone: in vitro activity against 410 bacterial isolates compared with cefotaxime.
Digranes A; Benonisen E; Dibb WL
Infection; 1982; 10(5):307-9. PubMed ID: 6293978
[TBL] [Abstract][Full Text] [Related]
16. Cefotaxime: a review of in vitro antimicrobial properties and spectrum of activity.
Jones RN; Thornsberry C
Rev Infect Dis; 1982; 4 Suppl():S300-15. PubMed ID: 6294779
[TBL] [Abstract][Full Text] [Related]
17. Comparative in-vitro activity of Sch 34343, imipenem, cefpirome and cefotaxime.
Bauernfeind A
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():155-64. PubMed ID: 3897170
[TBL] [Abstract][Full Text] [Related]
18. Combination of altered PBPs and expression of cloned extended-spectrum beta-lactamases confers cefotaxime resistance in Haemophilus influenzae.
Bozdogan B; Tristram S; Appelbaum PC
J Antimicrob Chemother; 2006 Apr; 57(4):747-9. PubMed ID: 16492720
[TBL] [Abstract][Full Text] [Related]
19. Cefmenoxime (SCE-1365), a new cephalosporin: in vitro activity, comparison with other antimicrobial agents, beta-lactamase stability, and disk diffusion testing with tentative interpretive criteria.
Fuchs PC; Jones RN; Thornsberry C; Barry AL; Gerlach EH; Sommers HM
Antimicrob Agents Chemother; 1981 Dec; 20(6):747-59. PubMed ID: 6275784
[TBL] [Abstract][Full Text] [Related]
20. In vitro antibacterial activity and beta-lactamase stability of cefodizime, a new cephalosporin antibiotic.
Kasai K; Tsuji A; Miyazaki S; Goto S; Fujimoto K; Masuyoshi S; Arai S
Jpn J Antibiot; 1984 Jul; 37(7):1294-305. PubMed ID: 6092739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
